Table 1 Initial peptides synthesized and tested for inhibitory activity.
From: Peptide inhibitors of dengue virus and West Nile virus infectivity
Peptide | Sequence | Locationa | Concentration (μM) | % Inhibition +/- SD |
|---|---|---|---|---|
DN80 | MVDRGWGNHAGLFGKGSIV | 386–400 | 49.9 | 17 +/- 10 |
DN57 | AWLVHTQWFLDLPLPWLPGADTQGSNWI | 485–503 | 30.6 | 7 +/- 4 |
DN81 | AWLVHRQWFLDLPLPWLPG | 485–512 | 42.6 | 25 +/- 8 |
DN59 | MAILGDTAWDFGSLGGVFTSIGKALHQVFGAIY | 692–724 | 29.0 | 93 +/- 2 |
WN82 | VVDRGWGNGAGLFGKGSID | 396–410 | 52.5 | 4 +/- 13 |
WN53 | TFLVHREWFMDLNLPWSSAGSTVWR | 500–518 | 98.7 | 56 +/- 5 |
WN83 | TFLVHREWFMDLNLPWSSA | 500–524 | 128.0 | 70 +/- 2 |